Peptide-powered wellness.
Direct-pay telehealth, 48 states + DC.
TelePeptide Health
Effective Date: April 3, 2026 · Last Revised: July 11, 2026
Please read this consent carefully. By submitting an intake form or proceeding with any TelePeptide Health program, you agree to the terms of this consent. If you have questions, contact help@telepeptide.org before proceeding.
TelePeptide Health provides telehealth services that connect you with a licensed clinician (through our contracted medical group) who holds an active license in your state of residence, for medical evaluation and, where clinically appropriate, prescribing. The identity of the contracted medical group is available to you on request. Telehealth means your evaluation may occur entirely through digital communication — written intake forms, asynchronous clinician review, and secure messaging — without an in-person visit. By submitting an intake request you consent to this model of care and acknowledge you understand the following: (a) telehealth has inherent limitations compared to in-person care, including an inability to perform physical examinations; (b) your clinician may require additional information, labs, or an in-person visit before prescribing; and (c) there is no guarantee a prescription will be issued based on your intake alone.
Submitting an intake form or making a payment does not guarantee you will receive a prescription, consultation, or medication. All prescribing decisions are made solely by the licensed independent clinician assigned to your case based on their professional medical judgment. TelePeptide Health does not direct or influence prescribing decisions. A clinician may decline to prescribe for any clinical reason, including but not limited to: contraindications, incomplete information, insufficient medical history, or clinical ineligibility for a specific medication or program.
Some treatment plans may involve compounded medications. Examples of active ingredients that may be compounded include semaglutide, tirzepatide, and sermorelin. The specific medication prescribed (if any) and the exact formulation will be determined by your licensed clinician based on individualized medical evaluation. By proceeding you acknowledge and consent to the following: (a) Compounded medications are not FDA-approved finished drug products. They are prepared by licensed 503A or 503B compounding pharmacies but have not undergone the same FDA review process as brand-name drugs. (b) The FDA has not independently evaluated the safety, efficacy, potency, or sterility of compounded versions of these medications. (c) Compounded medications are not generic versions of branded drugs and are not represented as therapeutically equivalent to any FDA-approved product. (d) Compounded medications may carry different risk profiles than FDA-approved equivalents. (e) You have the right to ask your clinician about alternatives, including FDA-approved branded medications, before agreeing to a compounded formulation. (f) You will discuss the specific risks and benefits of any prescribed compound with your clinician prior to dispensing.
Some medications prescribed through TelePeptide programs may be used in an off-label manner — meaning for a purpose, dose, or patient population not specifically approved by the FDA. Off-label prescribing is legal, widely practiced, and may reflect emerging clinical evidence. By proceeding you acknowledge that your clinician has disclosed or will disclose any off-label aspects of your treatment plan, and you consent to off-label use where your clinician determines it is appropriate based on current clinical evidence.
All medications and medical programs carry potential risks and side effects. GLP-1 agonists (semaglutide, tirzepatide) may cause nausea, vomiting, diarrhea, constipation, headache, fatigue, injection site reactions, and in rare cases pancreatitis or thyroid effects. Peptide therapies may have other profiles disclosed by your clinician. You acknowledge that: (a) your clinician will review known risks with you; (b) you must report any adverse reactions promptly; (c) you will follow all instructions provided by your prescribing clinician; and (d) TelePeptide Health is not liable for clinical outcomes, adverse reactions, or events arising from your treatment.
TelePeptide Health is not an emergency medical service. If you are experiencing a medical emergency, a life-threatening reaction, or severe adverse effects from any medication, call 911 or go to the nearest emergency room immediately. Do not contact TelePeptide through this platform for emergency care.
You consent to providing complete, accurate, and truthful medical history — including current medications, allergies, prior diagnoses, and family history — directly to the contracted medical group on its secure, HIPAA-covered platform (not to TelePeptide, which does not collect or store clinical information). You understand that inaccurate or incomplete information could result in harm, and that TelePeptide Health and the contracted clinicians are not liable for outcomes resulting from information you withheld or misrepresented.
Your clinical and health information is collected and held by the contracted medical group on its HIPAA-covered platform, where that group — not TelePeptide — is the covered entity. You authorize and direct TelePeptide to transmit the non-clinical setup identifiers needed to establish your visit (name, contact details, date of birth, biological sex, and mailing address) to that medical group to create your patient record. By proceeding you also consent to that medical group sharing your health information, as needed for your care and under its own HIPAA framework, with: (a) the licensed clinician assigned to your case in your state of residence; (b) the compounding pharmacy filling your prescription; (c) laboratory partners where testing is required; (d) other healthcare providers involved in your care; and (e) service partners and subcontractors that support the delivery of your care and this platform — for example, care-coordination, identity or eligibility verification, communications, payment, and shipment or logistics vendors. Any party that creates, receives, maintains, or transmits Protected Health Information on the medical group's or a pharmacy's behalf does so under a Business Associate Agreement, and TelePeptide's own service partners handle only non-clinical data under written data-protection agreements. TelePeptide itself does not collect, hold, or share your Protected Health Information — it transmits only the non-clinical identifiers needed to set up your visit, and you should not send health information to TelePeptide directly. Once information is shared with any of these parties at your authorization, that party is responsible for its own handling of it, and TelePeptide is not liable for the independent acts or omissions of the medical group, its clinicians, pharmacies, laboratories, or service partners. See our Privacy Practices at /privacy-practices for how this no-PHI structure works, and Terms § 10a for the full authorization.
You may withdraw your consent to telehealth services at any time by notifying us at help@telepeptide.org. Withdrawal of consent will stop future services but will not affect the legality of any services already rendered or any payment obligations already incurred. Your medical records are held and retained by the contracted medical group in accordance with the medical-records-retention laws of the patient's state of residence (typically at least 7 years for adult records, longer for minors); TelePeptide does not hold those clinical records.
By submitting an intake form or proceeding with any TelePeptide Health program, you confirm that: (a) you have read and understood this Informed Consent; (b) you have had the opportunity to ask questions; (c) you voluntarily consent to the services described; and (d) you are at least 18 years of age and legally competent to give consent.
TelePeptide Health · 2077 Center Ave, Fort Lee, NJ 07024 · help@telepeptide.org